4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design

4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design

Oncological diseases have currently reached an epidemic scale, especially in industrialized countries. Such a situation has prompted complex studies in medicinal chemistry focused on the research and development of novel effective anticancer drugs. In this review, the data concerning new 4-thiazolid...

Full description

Bibliographic Details
Main Authors: Piotr Roszczenko, Serhii Holota, Olga Klaudia Szewczyk, Rostyslav Dudchak, Krzysztof Bielawski, Anna Bielawska, Roman Lesyk
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
molecular hybridization
hybrid molecules
4-thiazolidinone
approved drugs
natural compounds
privileged heterocycles
Online Access:https://www.mdpi.com/1422-0067/23/21/13135

Internet

https://www.mdpi.com/1422-0067/23/21/13135

Similar Items